Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma	Recruiting	Phase 3	2022-03-03		NCT05044117

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Guangdong Medical University	27
Fujian Medical University Union Hospital	108
Guangzhou Panyu Central Hospital	5
Hanzhong Central Hospital	4
Hunan University of Medicine General Hospital	4
Jiangmen Central Hospital	27
Sun Yat-sen University	606
The Central Hospital of Yongzhou	2
Xiangyang No.1 People's Hospital	4
Yichang Central People's Hospital	24

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-sen University Cancer Center	Guangzhou	China	315